Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart ® in...
Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart ® in patients with multiple sclerosis
About this item
Full title
Author / Creator
Publisher
New Zealand: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
Adherence to disease-modifying drugs (DMDs) is one of the key factors for achieving optimal clinical outcomes. Rebismart
is an injection device for subcutaneous administration of interferon beta-1a (INF β-1a) that is also able to monitor adherence objectively. The aim of this study was to describe adherence to INF β-1a using the said electronic...
Alternative Titles
Full title
Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart ® in patients with multiple sclerosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9fa00ad9068842bbab9a3cfeea855c23
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9fa00ad9068842bbab9a3cfeea855c23
Other Identifiers
ISSN
1177-889X
E-ISSN
1177-889X
DOI
10.2147/PPA.S127508
